ZULRESSO (BREXANOLONE) — FDA Approval NDA211371 (SAGE THERAP)
ZULRESSO (BREXANOLONE) — FDA Approval NDA211371 (SAGE THERAP) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ZULRESSO; Active ingredients: BREXANOLONE; Application number: NDA211371.
| Brand name | ZULRESSO |
|---|---|
| Active ingredients | BREXANOLONE |
| Application number | NDA211371 |
| Sponsor | SAGE THERAP |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 20190319 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →